Sirna Therapeutics

About:

Sirna Therapeutics is a biotechnology company exploring the use of RNA interference in human disease therapy.

Website: http://www.sirna.com

Top Investors: Notable Capital, Venrock, Oxford Bioscience Partners, Techno Venture Management, Sprout Group

Description:

The scientific community considers RNA interference the breakthrough biological discovery of the decade with the potential to change how diseases are treated. Sirna Therapeutics is at the forefront of the effort to create RNAi- based therapies and leverage the vast potential of this technology to ultimately treat patients.

Total Funding Amount:

$86.9M

Headquarters Location:

San Francisco, California, United States

Founded Date:

1992-01-01

Founders:

Number of Employees:

51-100

Last Funding Date:

2023-08-10

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai